Published :
Tables : 63
Figures : 54
Category : Healthcare
No. of Pages : 243
Report Code : HC-U3353
Veterinary Immunodiagnostics Market Overview: Increased demand for food products derived from animals, growing livestock and companion animal population, increased disposable income for expenditure on animal healthcare are some of the primary factors contributing to the growth of the market. Furthermore, increased acceptance of animals in developed countries like the United States, growing favourable policies for the usage of better diagnostic products in animals are some other factors positively affecting the veterinary immunodiagnostics market growth. Market Segmentation: By Product Type • Analyzers • Consumables By Animal Type • Livestock o Cattle o Pigs o Poultry o Others • Companion o Feline o Canine o Equine o Others By Technology • Enzyme-Linked Immunosorbent Assay (ELISA) o Chemiluminescence Immunoassay o Fluorescent Immunoassay o Colorimetric Immunoassay • Radioimmunoassay • Rapid Test • Others By Application • Infectious Disease • Autoimmune Disorder • Endocrinology& Oncology • Bone and Mineral diseases • Others By End User • Reference Laboratories • Academic and Research Institutes • Veterinary Hospitals & Clinics • Point of care/ In-house testing By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is fragmented into animal type, product, application, technology, end user and region. The product segment is categorised into analysers and consumables. The consumables segment is anticipated to hold the largest veterinary immunodiagnostics market share and this can be credited to a rising insistence for animal diagnostics to prevent the transfer of zoonotic diseases in humans and ensuring that the products derived from animals are of good quality. The animal type segment is fragmented into companion and livestock animals. The livestock animals is anticipated to dominate the market during the forecast period and this is due to the increased investment in the livestock animal healthcare owing to a soaring demand for products based on animals from across the world. Regional Analysis: The North America region is predicted to dominate the market owing to advancements in the healthcare infrastructure, increased disposable income for animal healthcare, rising companion animal population in the United States and improving reimbursement policies for animal healthcare. Competitive Landscape: The prominent players of the market are Abaxisinc., bioMérieux SA, IDEXX Laboratories Inc., Heska Corporation, Virbac SA, Zoetisinc., Randox Laboratories Ltd., Neogen Corporation, Woodley Equipment Company Ltd, Thermo Fisher Scientific Inc., QIAGEN N.V. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global veterinary immunodiagnostics market by product type, by animal type, by technology, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Increased demand for food products derived from animals, growing livestock and companion animal population, increased disposable income for expenditure on animal healthcare are some of the primary factors contributing to the growth of the market. Furthermore, increased acceptance of animals in developed countries like the United States, growing favourable policies for the usage of better diagnostic products in animals are some other factors positively affecting the veterinary immunodiagnostics market growth.
Market Segmentation:
By Product Type • Analyzers • Consumables
By Animal Type • Livestock o Cattle o Pigs o Poultry o Others • Companion o Feline o Canine o Equine o Others
By Technology • Enzyme-Linked Immunosorbent Assay (ELISA) o Chemiluminescence Immunoassay o Fluorescent Immunoassay o Colorimetric Immunoassay • Radioimmunoassay • Rapid Test • Others
By Application • Infectious Disease • Autoimmune Disorder • Endocrinology& Oncology • Bone and Mineral diseases • Others
By End User • Reference Laboratories • Academic and Research Institutes • Veterinary Hospitals & Clinics • Point of care/ In-house testing
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is fragmented into animal type, product, application, technology, end user and region. The product segment is categorised into analysers and consumables. The consumables segment is anticipated to hold the largest veterinary immunodiagnostics market share and this can be credited to a rising insistence for animal diagnostics to prevent the transfer of zoonotic diseases in humans and ensuring that the products derived from animals are of good quality. The animal type segment is fragmented into companion and livestock animals. The livestock animals is anticipated to dominate the market during the forecast period and this is due to the increased investment in the livestock animal healthcare owing to a soaring demand for products based on animals from across the world.
Regional Analysis:
The North America region is predicted to dominate the market owing to advancements in the healthcare infrastructure, increased disposable income for animal healthcare, rising companion animal population in the United States and improving reimbursement policies for animal healthcare.
Competitive Landscape:
The prominent players of the market are Abaxisinc., bioMérieux SA, IDEXX Laboratories Inc., Heska Corporation, Virbac SA, Zoetisinc., Randox Laboratories Ltd., Neogen Corporation, Woodley Equipment Company Ltd, Thermo Fisher Scientific Inc., QIAGEN N.V.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global veterinary immunodiagnostics market by product type, by animal type, by technology, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Veterinary Immunodiagnostics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Veterinary Immunodiagnostics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Veterinary Immunodiagnostics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Veterinary Immunodiagnostics Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Analyzers 7.2 Consumables 8. Veterinary Immunodiagnostics Market, By Animal Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Livestock 8.1.1. Cattle 8.1.2. Pigs 8.1.3. Poultry 8.1.4. Others 8.2. Companion 8.2.1. Feline 8.2.2. Canine 8.2.3. Equine 8.2.4. Others 9. Veterinary Immunodiagnostics Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Enzyme-Linked Immunosorbent Assay (ELISA) 9.1.1 Chemiluminescence Immunoassay 9.1.2 Fluorescent Immunoassay 9.1.3 Colorimetric Immunoassay 9.2 Radioimmunoassay 9.3 Rapid Test 9.4 Others 10. Veterinary Immunodiagnostics Market, By Applications Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Infectious Disease 10.2 Autoimmune Disorder 10.3 Endocrinology & Oncology 10.4 Bone and Mineral Diseases 10.5 Others 11. Veterinary Immunodiagnostics Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Reference Laboratories 11.2 Academic and Research Institutes 11.3 Veterinary Hospitals and Clinics 11.4 Point of Care/ In-house Testing 12. North America Veterinary Immunodiagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028 13. Latin America Veterinary Immunodiagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028 14. Europe Veterinary Immunodiagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028 15. Asia Pacific Veterinary Immunodiagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Abaxisincl 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. bioMérieux SA 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. IDEXX Laboratories Inc. 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Heska Corporation 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Virbac SA 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Zoetis inc. 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Randox Laboratories Ltd. 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Neogen Corporation 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Woodley Equipment Company Ltd 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Thermo Fisher Scientific Inc. 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11.QIAGEN N.V 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Veterinary Immunodiagnostics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Veterinary Immunodiagnostics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Veterinary Immunodiagnostics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Veterinary Immunodiagnostics Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Analyzers 7.2 Consumables
8. Veterinary Immunodiagnostics Market, By Animal Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Livestock 8.1.1. Cattle 8.1.2. Pigs 8.1.3. Poultry 8.1.4. Others 8.2. Companion 8.2.1. Feline 8.2.2. Canine 8.2.3. Equine 8.2.4. Others
9. Veterinary Immunodiagnostics Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Enzyme-Linked Immunosorbent Assay (ELISA) 9.1.1 Chemiluminescence Immunoassay 9.1.2 Fluorescent Immunoassay 9.1.3 Colorimetric Immunoassay 9.2 Radioimmunoassay 9.3 Rapid Test 9.4 Others
10. Veterinary Immunodiagnostics Market, By Applications Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Infectious Disease 10.2 Autoimmune Disorder 10.3 Endocrinology & Oncology 10.4 Bone and Mineral Diseases 10.5 Others
11. Veterinary Immunodiagnostics Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Reference Laboratories 11.2 Academic and Research Institutes 11.3 Veterinary Hospitals and Clinics 11.4 Point of Care/ In-house Testing
12. North America Veterinary Immunodiagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028
13. Latin America Veterinary Immunodiagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028
14. Europe Veterinary Immunodiagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028
15. Asia Pacific Veterinary Immunodiagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028
17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix
18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Abaxisincl 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. bioMérieux SA 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. IDEXX Laboratories Inc. 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Heska Corporation 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Virbac SA 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Zoetis inc. 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Randox Laboratories Ltd. 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Neogen Corporation 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Woodley Equipment Company Ltd 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Thermo Fisher Scientific Inc. 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11.QIAGEN N.V 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview
19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations
20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics